Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa

被引：46
作者：
Gelfand, Michael S. [1 ]
Cleveland, Kerry O. [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Div Infect Dis, Dept Med, Memphis, TN 38163 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2015年 / 61卷 / 05期
关键词：
PNEUMONIA;
D O I：
10.1093/cid/civ411
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：853 / U207
页数：3
相关论文
共 6 条
[1]  
[Anonymous], 2014, ZERBAXA CEFT TAZ PAC
[2]  
ClinicalTrialsgov, SAF EFF STUD CEFT TA
[3]   Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012) [J].
Farrell, David J. ;
Sader, Helio S. ;
Flamm, Robert K. ;
Jones, Ronald N. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (06) :533-539
[4]   Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa [J].
Kollef, Marin H. ;
Chastre, Jean ;
Fagon, Jean-Yves ;
Francois, Bruno ;
Niederman, Michael S. ;
Rello, Jordi ;
Torres, Antoni ;
Vincent, Jean-Louis ;
Wunderink, Richard G. ;
Go, Kerry W. ;
Rehm, Christine .
CRITICAL CARE MEDICINE, 2014, 42 (10) :2178-2187
[5]   Bloodstream Infection Caused by Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteria: How to Define the Best Treatment Regimen? [J].
Perez, Federico ;
Bonomo, Robert A. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (09) :1326-1329
[6]   Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI) [J].
Solomkin, Joseph ;
Hershberger, Ellie ;
Miller, Benjamin ;
Popejoy, Myra ;
Friedland, Ian ;
Steenbergen, Judith ;
Yoon, Minjung ;
Collins, Sylva ;
Yuan, Guojun ;
Barie, Philip S. ;
Eckmann, Christian .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) :1462-1471
1